190 related articles for article (PubMed ID: 16533193)
1. Experience with the synthetic cannabinoid nabilone in chronic noncancer pain.
Berlach DM; Shir Y; Ware MA
Pain Med; 2006; 7(1):25-9. PubMed ID: 16533193
[TBL] [Abstract][Full Text] [Related]
2. The effects of nabilone on sleep in fibromyalgia: results of a randomized controlled trial.
Ware MA; Fitzcharles MA; Joseph L; Shir Y
Anesth Analg; 2010 Feb; 110(2):604-10. PubMed ID: 20007734
[TBL] [Abstract][Full Text] [Related]
3. Randomized, controlled trial of cannabis-based medicine in central pain in multiple sclerosis.
Rog DJ; Nurmikko TJ; Friede T; Young CA
Neurology; 2005 Sep; 65(6):812-9. PubMed ID: 16186518
[TBL] [Abstract][Full Text] [Related]
4. Adjunctive nabilone in cancer pain and symptom management: a prospective observational study using propensity scoring.
Maida V; Ennis M; Irani S; Corbo M; Dolzhykov M
J Support Oncol; 2008 Mar; 6(3):119-24. PubMed ID: 18402303
[TBL] [Abstract][Full Text] [Related]
5. Superiority of nabilone over prochlorperazine as an antiemetic in patients receiving cancer chemotherapy.
Herman TS; Einhorn LH; Jones SE; Nagy C; Chester AB; Dean JC; Furnas B; Williams SD; Leigh SA; Dorr RT; Moon TE
N Engl J Med; 1979 Jun; 300(23):1295-7. PubMed ID: 375088
[TBL] [Abstract][Full Text] [Related]
6. Comparison of analgesic effects and patient tolerability of nabilone and dihydrocodeine for chronic neuropathic pain: randomised, crossover, double blind study.
Frank B; Serpell MG; Hughes J; Matthews JN; Kapur D
BMJ; 2008 Jan; 336(7637):199-201. PubMed ID: 18182416
[TBL] [Abstract][Full Text] [Related]
7. [Randomized comparative trial of a new anti-emetic: nabilone, in cancer patients treated with cisplatin].
George M; Pejovic MH; Thuaire M; Kramar A; Wolff JP
Biomed Pharmacother; 1983; 37(1):24-7. PubMed ID: 6311306
[TBL] [Abstract][Full Text] [Related]
8. Long-term management of chronic pain with transdermal buprenorphine: a multicenter, open-label, follow-up study in patients from three short-term clinical trials.
Likar R; Kayser H; Sittl R
Clin Ther; 2006 Jun; 28(6):943-52. PubMed ID: 16860176
[TBL] [Abstract][Full Text] [Related]
9. A study of AVINZA (morphine sulfate extended-release capsules) for chronic moderate-to-severe noncancer pain conducted under real-world treatment conditions--the ACCPT Study.
Adams EH; Chwiecko P; Ace-Wagoner Y; Mangefrida B; Duerden ME; Perdikis GC; Kunkel FA; Ghalie R
Pain Pract; 2006 Dec; 6(4):254-64. PubMed ID: 17129306
[TBL] [Abstract][Full Text] [Related]
10. Substitution profile of the cannabinoid agonist nabilone in human subjects discriminating δ9-tetrahydrocannabinol.
Lile JA; Kelly TH; Hays LR
Clin Neuropharmacol; 2010; 33(5):235-42. PubMed ID: 20838217
[TBL] [Abstract][Full Text] [Related]
11. A randomized, double-blind, placebo-controlled study of preemptively administered intravenous parecoxib: effect on anxiety levels and procedural pain during epidural catheter placement for surgical operations or for chronic pain therapy.
Vadalouca A; Moka E; Chatzidimitriou A; Siafaka I; Sikioti P; Argyra E
Pain Pract; 2009; 9(3):181-94. PubMed ID: 19298364
[TBL] [Abstract][Full Text] [Related]
12. Nabilone for the treatment of pain in fibromyalgia.
Skrabek RQ; Galimova L; Ethans K; Perry D
J Pain; 2008 Feb; 9(2):164-73. PubMed ID: 17974490
[TBL] [Abstract][Full Text] [Related]
13. Are oral cannabinoids safe and effective in refractory neuropathic pain?
Attal N; Brasseur L; Guirimand D; Clermond-Gnamien S; Atlami S; Bouhassira D
Eur J Pain; 2004 Apr; 8(2):173-7. PubMed ID: 14987627
[TBL] [Abstract][Full Text] [Related]
14. Oromucosal delta9-tetrahydrocannabinol/cannabidiol for neuropathic pain associated with multiple sclerosis: an uncontrolled, open-label, 2-year extension trial.
Rog DJ; Nurmikko TJ; Young CA
Clin Ther; 2007 Sep; 29(9):2068-79. PubMed ID: 18035205
[TBL] [Abstract][Full Text] [Related]
15. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
[TBL] [Abstract][Full Text] [Related]
16. Sleep quality and the role of sleep medications for veterans with chronic pain.
Chapman JB; Lehman CL; Elliott J; Clark JD
Pain Med; 2006; 7(2):105-14. PubMed ID: 16634723
[TBL] [Abstract][Full Text] [Related]
17. The abuse potential of the synthetic cannabinoid nabilone.
Ware MA; St Arnaud-Trempe E
Addiction; 2010 Mar; 105(3):494-503. PubMed ID: 20402993
[TBL] [Abstract][Full Text] [Related]
18. Intrathecal narcotic infusion pumps for intractable pain of chronic pancreatitis: a pilot series.
Kongkam P; Wagner DL; Sherman S; Fogel EL; Whittaker SC; Watkins JL; McHenry L; Lehman GA
Am J Gastroenterol; 2009 May; 104(5):1249-55. PubMed ID: 19367269
[TBL] [Abstract][Full Text] [Related]
19. Cannabis, pain, and sleep: lessons from therapeutic clinical trials of Sativex, a cannabis-based medicine.
Russo EB; Guy GW; Robson PJ
Chem Biodivers; 2007 Aug; 4(8):1729-43. PubMed ID: 17712817
[TBL] [Abstract][Full Text] [Related]
20. Reassessment of the role of cannabinoids in the management of pain.
Beaulieu P; Ware M
Curr Opin Anaesthesiol; 2007 Oct; 20(5):473-7. PubMed ID: 17873600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
